SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-51402"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-51402" > Early abciximab adm...

  • Rakowski, TomaszJagiellonian University (författare)

Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER Registry

  • Artikel/kapitelEngelska2009

Förlag, utgivningsår, omfång ...

  • Elsevier BV,2009
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-51402
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-51402URI
  • https://doi.org/10.1016/j.ahj.2009.08.008DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background There are conflicting data on the clinical benefit from early administration of abciximab from a large randomized trial and a registry. However, both sources suggest that a benefit may depend on the baseline risk profile of the patients. We evaluated the role of early abciximab administration in patients with ST-segment-elevation myocardial infarction (STEMI) referred for primary percutaneous coronary intervention stratified by the STEMI Thrombolysis In Myocardial Infarction (TIMI) risk score. Methods A total of 1,650 patients were enrolled into the EUROTRANSFER Registry. One thousand eighty-six patients received abciximab (66%). Abciximab was administered early in 727 patients (EA) and late in 359 patients (LA). We used the TIMI risk score for risk stratification. Patients with scores 3 constituted the high-risk group of 616 patients (56.7%), whereas 470 patients formed the low-risk cohort. Factoring in the timing of the abciximab administration resulted in 4 groups of patients who were compared for mortality at 1 year: EA/high-risk (n = 413); LA/high-risk (n = 203); EA/low-risk (n = 3 14); LA/low-risk (n = 156). Baseline difference was accounted for by means of propensity score. Results In high-risk patients, 1-year mortality was significantly lower with early abcximab compared to late administration (8.7% vs 15.8%; odds ratio 0.51, CI 0.31-0.85, P = .01). In multivariable Cox regression analysis, both early abciximab administration and patients risk profile (TIMI score :3) were identified as independent predictors of 1-year mortality. Conclusions Early abciximab administration before transfer for percutaneous coronary intervention in STEMI shows lower mortality at 1-year follow-up. This effect is confined to patients with higher risk profile as defined by TIMI risk score andgt;= 3.

Ämnesord och genrebeteckningar

  • MEDICINE
  • MEDICIN

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Siudak, ZbigniewJagiellonian University (författare)
  • Dziewierz, ArturJagiellonian University (författare)
  • Birkemeyer, RalfSchwarzwald Baar Klinikum Villingen Schwenningen (författare)
  • Legutko, JacekJagiellonian University (författare)
  • Mielecki, WaldemarJagiellonian University (författare)
  • Depukat, RafalJagiellonian University (författare)
  • Janzon, MagnusÖstergötlands Läns Landsting,Linköpings universitet,Kardiologi,Hälsouniversitetet,Kardiologiska kliniken(Swepub:liu)magja75 (författare)
  • Stefaniak, JustynaKrakow Cardiovasc Research Institute (författare)
  • Zmudka, KrzysztofJagiellonian University (författare)
  • Dubiel, Jacek SJagiellonian University (författare)
  • Partyka, LukaszKrakow Cardiovasc Research Institute (författare)
  • Dudek, DariuszJagiellonian University (författare)
  • Jagiellonian UniversitySchwarzwald Baar Klinikum Villingen Schwenningen (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:AMERICAN HEART JOURNAL: Elsevier BV158:4, s. 569-5750002-8703

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy